Improved IVF Outcomes With Interpregnancy Interval of at Least Six Months
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 1, 2023 -- For women undergoing in vitro fertilization (IVF), delaying the next frozen embryo transfer (FET) for at least six months after a clinical pregnancy loss (CPL) is associated with improved pregnancy outcomes, according to a study published online Oct. 31 in JAMA Network Open.
Ze Wang, M.D., from Shandong University in Jinan, China, and colleagues examined the association between different interpregnancy interval (IPI) lengths after a preceding CPL and pregnancy outcomes of the next FET in a retrospective cohort study involving women who underwent frozen-thawed blastocyst transfer within one year after a CPL during IVF treatment. The analysis included 2,433 women who received IVF treatment: 13.9, 55.4, and 30.7 percent with a IPI of less than three months, three to less than six months, and six to 12 months, respectively.
The researchers found that shorter IPIs (less than three and three to less than six months) were associated with reduced odds of clinical pregnancy (adjusted odds ratios, 0.70 and 0.79, respectively), live birth (adjusted odds ratios, 0.64 and 0.74, respectively), and healthy live birth (adjusted odds ratios, 0.63 and 0.79, respectively) compared with an IPI of six to 12 months. Women with shorter IPIs had a higher risk of total pregnancy loss (adjusted odds ratios, 1.87 and 1.29, respectively) compared to women with an IPI of six to 12 months.
"The causal mechanisms that underlie the association between a short IPI and unfavorable pregnancy outcomes remain unclear," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
NT-proBNP, IL-1RL Can Identify High-Risk Congenital Heart Disease in Neonates
MONDAY, June 24, 2024 -- Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital heart disease (CHD) in newborns...
Maternal Distress Tied to Changes in Brain Growth of Offspring
FRIDAY, June 21, 2024 -- Regional neonatal brain volumes are associated with elevated maternal psychological distress, according to a study published online June 20 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.